These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1708877)
1. Effects of stress and beta 1 blockade on the ventricular depolarization gradient of the rate modulating pacemaker. Singer I; Brennan AF; Steinhaus B; Maldonado C; Kupersmith J Pacing Clin Electrophysiol; 1991 Mar; 14(3):460-9. PubMed ID: 1708877 [TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and onset of action of esmolol in anesthetized dogs. Quon CY; Gorczynski RJ J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328 [TBL] [Abstract][Full Text] [Related]
3. The effects of esmolol and dexmedetomidine on myocardial oxygen consumption during sympathetic stimulation in dogs. Willigers HM; Prinzen FW; Roekaerts PM J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):364-70. PubMed ID: 16750737 [TBL] [Abstract][Full Text] [Related]
4. Esmolol: effects on isoprenaline- and exercise-induced cardiovascular stimulation in conscious dogs. Fischer G; Grohs JG; Raberger G Can J Physiol Pharmacol; 1990 Oct; 68(10):1322-8. PubMed ID: 1981854 [TBL] [Abstract][Full Text] [Related]
5. Is esmolol cardioprotective? Tolerance of pacing tachycardia, acute afterloading and hemodilution in dogs with coronary stenosis. Spahn DR; Frasco PE; White WD; Smith LR; McRae RL; Leone BJ J Am Coll Cardiol; 1993 Mar; 21(3):809-21. PubMed ID: 8094722 [TBL] [Abstract][Full Text] [Related]
6. Effect of esmolol on the ventricular fibrillation threshold. Wallis DE; Wedel VA; Scanlon PJ; Euler DE Pharmacology; 1988; 36(1):9-15. PubMed ID: 2893394 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and antiarrhythmic effects of esmolol in children. Trippel DL; Wiest DB; Gillette PC J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729 [TBL] [Abstract][Full Text] [Related]
8. An enantiomerically pure formulation of esmolol attenuates hypotension and preserves heart rate control in dogs. McKee JS; Rabinow BE; Daller JR; Brooks BD; Baumgartner B; Rohatgi P Anesthesiology; 2014 Dec; 121(6):1184-93. PubMed ID: 25105423 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary reactivity to methacholine during beta-adrenergic blockade: propranolol versus esmolol. Tobias JD; Sauder RA; Hirshman CA Anesthesiology; 1990 Jul; 73(1):132-6. PubMed ID: 1972872 [TBL] [Abstract][Full Text] [Related]
10. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol. Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. Sugiyama A; Takahara A; Hashimoto K J Cardiovasc Pharmacol; 1999 Jul; 34(1):70-7. PubMed ID: 10413070 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive assessment of the direct action of oral nifedipine and nicardipine on left ventricular contractile state in patients with systemic hypertension: importance of reflex sympathetic responses. Borow KM; Neumann A; Lang RM; Ehler D; Valentine-Bates B; Wolff A; Friday K; Murphy M J Am Coll Cardiol; 1993 Mar; 21(4):939-49. PubMed ID: 8095507 [TBL] [Abstract][Full Text] [Related]
15. Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography. Cork RC; Azari DM; McQueen KA; Aufderheide S; Mitchell M; Naraghi M Anesth Analg; 1995 Aug; 81(2):219-24. PubMed ID: 7618705 [TBL] [Abstract][Full Text] [Related]